by [150+ Pages Report]According to Report, the orthopedic biomaterials market size is expected to reach around US$ 26.5 billion by 2027 and is anticipated to grow at a CAGR of 9.83% during forecast period 2021 to 2027, according to Precedence Research.
The orthopedic biomaterials market report covers a detailed analysis for the historic period 2017-2020, considering 2021 as the base year and forecast (growth) for 2021-2027.
This research report evaluates the orthopedic biomaterials market on a global and regional level. It offers a thorough analysis of the market revenue status, growth, future trends, and forecast of the global orthopedic biomaterials market for the period from 2017 to 2027.
Download Free Sample Copy with TOC, Graphs & List of Figures @ https://www.precedenceresearch.com/sample/1107
Market Report Scope
| Report Highlights | Details |
| Market Size | USD 26.5 Billion by 2027 |
| Growth Rate | CAGR of 9.83% from 2021 to 2027 |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2021 to 2027 |
This report enables readers to make important decisions with regard to their business, with the help of a wealth of Information enclosed in the study. The report also provides the compound annual growth rate (CAGR) of the global orthopedic biomaterials market for the forecast period of 2021–2027. This data can help readers interpret quantitative growth aspects of the global market during the forecast period. It presents a wealth of information on key market dynamics, including drivers, market trends, and challenges, as well as the structure of the global market across the globe.
The report analyzes the historical and present-day scenario of the global orthopedic biomaterials market to accurately gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the global market in order to identify opportunities for stakeholders.
For More Information or Query or Customization Before Buying, Visit @ https://www.precedenceresearch.com/customization/1107
Growth Factors
Growing prevalence of musculoskeletal diseases and disorders are the key driving factors for the growth of orthopedic biomaterials market. The reason for the occurrences of musculoskeletal disorder is orthopedic trauma or injury which affect the muscles, ligaments, tendons, bone and nervous. The orthopedic trauma affects the musculoskeletal systems. Increasing usage of nanoparticles in to orthopedic bioimplant will further propel the growth of the market. Currently, R&D activities into in the healthcare sector continuously focus to develop the treatment, therapies and medications for degenerative diseases.
One of the crucial influences for the market growth is changing consumer preferences from traditional materials to nanophase materials. Considerable benefits of biomaterials led substantial inventions in the regenerative medicines sector in the past couple of years. Increasing awareness among young generations towards health care and increasing geriatric population is expected to boost the growth of the orthopedic biomaterials market. Additionally, increasing demand for medical implant, substantial growth in the cardiovascular diseases escalates the growth of the market.
However, procedure of manufacturing biomaterials is very time consuming and must go through biocompatibility testing and clinical trials which hampers the market growth. Nonetheless, growth in the adoption of implantable devices, increasing patient population and availability of flexible government regulations in the emerging region is projected to offer significant growth avenues for orthopedic biomaterials market over the forecast period.
Regionally, the orthopedic biomaterials market has been segmented into North America, Europe, Asia Pacific, Middle East & Africa. North America dominated global orthopedic biomaterials market in 2019 owing to increasing demand for technologically advanced orthopedic implants. North America is projected to further mirror this trend throughout the prediction period.
Europe closely followed North America owing to cumulative orthopedic surgery cases and increasing focus on health care. Lack of awareness and availability of treatment facilities in the Middle East and Africa witness the slow growth in the orthopedic biomaterials market.
Asia Pacific is expected to record the highest CAGR over the forecast period. Growing healthcare industry in Japan, budding demand for cosmetic and plastic surgeries in India and less stringent tax policy in China and escalating elderly population drives the orthopedic biomaterials market significantly in this region.
Key Highlights
- Companies involved in the marketplace are focusing on developing innovative orthopedic biomaterials at competitive prices.
- The arrival of 3D printing is projected to substantially enhance the demand for orthopedic biomaterials due to benefits coupled with fabricating scaffolds.
- Increasing prevalence of bone degenerative diseases and bone disorders in low- and middle-income countries drives the regional market growth.
- Significant average selling price of the orthopedic implants, favorable coverage of orthopedic procedure and growing demand for technologically advanced orthopedic implants from surgeons with enhanced lifetime and quality flourishes the growth in developed region.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1107
Competition Landscape
In the final section of the research report, Precedence Research provided the global orthopedic biomaterials market structure and a detailed competition landscape to provide a dashboard view of key players operating in the global market along with their business strategies to report audiences. This section is primarily designed to provide clients with an objective and detailed comparative assessment of the key providers specific to a market segment in the value chain of the market.
Some of the major players in the orthopedic biomaterials market include:
- Acumed, LLC
- Medtronic plc
- Globus Medical, Inc.
- Stryker Corporation
- Koninklijke DSM N.V.
- Exactech, Inc.
- Johnson & Johnson
- Zimmer Biomet
- Wright Medical Group, Inc.
- NuVasive, Inc.
Market Segmentation
By Material Outlook
- Polymers
- Ceramics & Bioactive Glasses
- Calcium Phosphate Cement
- Composites
- Metal
By Application Outlook
- Orthobiologics
- Orthopedic Implants
- Viscosupplementation
- Joint Replacement
- Bio-resorbable Tissue Fixation
Regional Segmentation
– North America (U.S. and Canada)
– Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
– Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
– Latin America (Brazil and Rest of Latin America)
– Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
- Market estimate for 2020
- Average selling price (ASP) per region for specific product type
- Filtrations and assortment of gathered data, to estimate the base year (2021) market size for the country
- Gathering data from company websites, annual reports, white papers, financial reports, broker reports, investor presentations, and SEC filings
- National government documents, statistical databases
- News articles, press releases, and webcasts specific to companies operating in the market
- Country wise analysis through internal and external proprietary databases, and relevant patent and regulatory databases
- Determination of market penetration by country
Most Asked Questions –
What was the market size value of the orthopedic biomaterials in 2020?
What is the expected market size by 2027?
What is the orthopedic biomaterials market growth?
What are the key factors that positively influence market growth?
Who are the prominent players in the orthopedic biomaterials market?
Why Buy this Report?
The purpose of Precedence Research’s orthopedic biomaterials market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Orthopedic Biomaterials Market, By Material
7.1. Orthopedic Biomaterials Market, by Material Type, 2020-2027
7.1.1. Polymers
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Ceramics & Bioactive Glasses
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Calcium Phosphate Cement
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Composites
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Metal
7.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Orthopedic Biomaterials Market, By Application
8.1. Orthopedic Biomaterials Market, by Application, 2020-2027
8.1.1. Orthobiologics
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Orthopedic Implants
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Viscosupplementation
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Joint Replacement
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Bio-resorbable Tissue Fixation
8.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Orthopedic Biomaterials Market, Regional Estimates and Trend Forecast
9.1. North America
9.1.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.1.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.2.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.3.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.4.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Material (2016-2027)
9.4.6.2. Market Revenue and Forecast, by Application (2016-2027)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.3.2. Market Revenue and Forecast, by Application (2016-2027)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Material (2016-2027)
9.5.4.2. Market Revenue and Forecast, by Application (2016-2027)
Chapter 10. Company Profiles
10.1. Acumed, LLC
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Medtronic plc
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Globus Medical, Inc.
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker Corporation
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Koninklijke DSM N.V.
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Exactech, Inc.
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Johnson & Johnson
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Zimmer Biomet
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Wright Medical Group, Inc.
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive, Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
Chapter 11. Research Methodology
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
Chapter 12. Appendix
12.1. About Us
12.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Purchase Full Research Report (Single User License US$ 4500) @ https://www.precedenceresearch.com/checkout/1107
About Us
Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: mailto:sales@precedenceresearch.com
For Latest Update Follow Us:
https://www.linkedin.com/company/precedence-research/
